REFERENCES
1. Miller KD, Goding Sauer A, Ortiz AP, et al. Cancer statistics for hispanics/latinos, 2018. CA Cancer J Clin. 2018;68:425-45.
2. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.
3. Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009.
4. Warren AY, Harrison D. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies. World J Urol. 2018;36:1913-26.
5. Pandolfo SD, Wu Z, Campi R, et al. Outcomes and techniques of robotic-assisted partial nephrectomy (RAPN) for renal hilar masses: a comprehensive systematic review. Cancers. 2024;16:693.
6. Fiorentino V, Tralongo P, Larocca LM, Pizzimenti C, Martini M, Pierconti F. First-line ICIs in renal cell carcinoma. Hum Vaccin Immunother. 2023;19:2225386.
7. Gill DM, Hahn AW, Hale P, Maughan BL. Overview of current and future first-line systemic therapy for metastatic clear cell renal cell carcinoma. Curr Treat Options Oncol. 2018;19:6.
8. Larroquette M, Peyraud F, Domblides C, et al. Adjuvant therapy in renal cell carcinoma: current knowledges and future perspectives. Cancer Treat Rev. 2021;97:102207.
9. Vasudev NS, Wilson M, Stewart GD, et al. Challenges of early renal cancer detection: symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open. 2020;10:e035938.
10. Pavlakis GM, Sakorafas GH, Anagnostopoulos GK. Intestinal metastases from renal cell carcinoma: a rare cause of intestinal obstruction and bleeding. Mt Sinai J Med. 2004;71:127-30.
11. Campbell S, Uzzo RG, Allaf ME, et al. Renal mass and localized renal cancer: AUA guideline. J Urol. 2017;198:520-9.
12. Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol. 2004;183:1387-91.
13. Cimadamore A, Franzese C, Di Loreto C, et al. Predictive and prognostic biomarkers in urological tumours. Pathology. 2024;56:228-38.
14. Kirschner MB, Kao SC, Edelman JJ, et al. Haemolysis during sample preparation alters microRNA content of plasma. PLoS One. 2011;6:e24145.
15. Gopalan V, Smith RA, Lam AK. Downregulation of microRNA-498 in colorectal cancers and its cellular effects. Exp Cell Res. 2015;330:423-8.
16. Ghasemi E, Mondanizadeh M, Almasi-Hashiani A, Mahboobi E. The significance of miR-124 in the diagnosis and prognosis of glioma: a systematic review. PLoS One. 2024;19:e0312250.
17. Long C, Shi H, Li J, et al. The diagnostic accuracy of urine-derived exosomes for bladder cancer: a systematic review and meta-analysis. World J Surg Oncol. 2024;22:285.
18. Park JS, Choi JA, Hyun DH, et al. Revisiting the diagnostic performance of exosomes: harnessing the feasibility of combinatorial exosomal miRNA profiles for colorectal cancer diagnosis. Discov Oncol. 2024;15:605.
19. Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12:697.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402-8.
21. Piperigkou Z, Karamanos NK. Dynamic Interplay between miRNAs and the Extracellular Matrix Influences the Tumor Microenvironment. Trends Biochem Sci. 2019;44:1076-88.
22. Zhang C, Zhao Y, Xu X, et al. Cancer diagnosis with DNA molecular computation. Nat Nanotechnol. 2020;15:709-15.
23. Zhou X, Liu G, Xu M, et al. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma. Mol Carcinog. 2022;61:508-23.
24. Friedrich M, Heimer N, Stoehr C, et al. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma. Sci Rep. 2020;10:6499.
25. Gao C, Zou X, Chen H, Shang R, Wang B. Long non-coding RNA nuclear paraspeckle assembly transcript 1 (NEAT1)relieves sepsis-induced kidney injury and lipopolysaccharide (LPS)-induced inflammation in HK-2 cells. Med Sci Monit. 2020;26:e921906.
26. Oghumu S, Bracewell A, Nori U, et al. Acute pyelonephritis in renal allografts-a new role for microRNAs? Transplantation. 2014;97:559-68.
27. Wang SY, Xu Y, Hong Q, Chen XM, Cai GY. Mesenchymal stem cells ameliorate cisplatin-induced acute kidney injury via let-7b-5p. Cell Tissue Res. 2023;392:517-33.
28. Dai Y, Liu J, Li X, et al. Let-7b-5p inhibits colon cancer progression by prohibiting APC ubiquitination degradation and the Wnt pathway by targeting NKD1. Cancer Sci. 2023;114:1882-97.
29. Huang X, Dong H, Liu Y, et al. Silencing of let-7b-5p inhibits ovarian cancer cell proliferation and stemness characteristics by Asp-Glu-Ala-Asp-box helicase 19A. Bioengineered. 2021;12:7666-77.
30. Zhang X, Wang Z, Zeng Z, et al. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell renal cell carcinoma. Cancer Cell Int. 2021;21:222.
31. Jingushi K, Uemura M, Nakano K, et al. Leukocyte-associated immunoglobulin-like receptor 1 promotes tumorigenesis in RCC. Oncol Rep. 2019;41:1293-303.
32. Gan J, Zhang H. PTPRO predicts patient prognosis and correlates with immune infiltrates in human clear cell renal cell carcinoma. Transl Cancer Res. 2020;9:4800-10.
33. Xu CL, Chen L, Li D, Chen FT, Sha ML, Shao Y. Acyl-CoA thioesterase 8 and 11 as novel biomarkers for clear cell renal cell carcinoma. Front Genet. 2020;11:594969.
34. Zhong G, Li Q, Luo Y, et al. FECH expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. J Oncol. 2022;2022:8943643.
35. Weygant N, Qu D, May R, et al. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma. Oncotarget. 2015;6:2193-205.